News

Zacks.com on MSN2mon
Hologic Wins Key Approvals Post Q1 Results: Buy or Hold HOLX Stock?
Meanwhile, the Aptima SARS-CoV-2 assay, initially granted Emergency Use Authorization status in May 2020, has now achieved ...
ETF Daily News8d
Hologic (NASDAQ:HOLX) Given New $62.00 Price Target at Evercore ISI
It provides Aptima molecular ... and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. Receive News & Ratings for Hologic Daily - Enter your email ...
ETF Daily News17d
Hologic, Inc. (NASDAQ:HOLX) Given Average Recommendation of “Hold” by Analysts
It provides Aptima molecular ... and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. Receive News & Ratings for Hologic Daily - Enter your email ...
Nasdaq14d
GYN Surgical Division Likely to Drive Hologic's Q2 Earnings
Additionally, the respiratory 4-plex, COVID/Flu A/B/RSV assay may have contributed to Diagnsotics’ growth in the second quarter. In February 2025, Hologic’s Aptima SARS-CoV-2 assay was granted ...